0001705194-18-000002.txt : 20180117 0001705194-18-000002.hdr.sgml : 20180117 20180116183444 ACCESSION NUMBER: 0001705194-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180117 DATE AS OF CHANGE: 20180116 EFFECTIVENESS DATE: 20180117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDel, INC. CENTRAL INDEX KEY: 0001705194 IRS NUMBER: 460692801 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-303381 FILM NUMBER: 18529513 BUSINESS ADDRESS: STREET 1: 423 WEST 127TH STREET CITY: NEW YORK STATE: NY ZIP: 10027 BUSINESS PHONE: 646-820-0066 MAIL ADDRESS: STREET 1: 423 WEST 127TH STREET CITY: NEW YORK STATE: NY ZIP: 10027 FORMER COMPANY: FORMER CONFORMED NAME: CytoDel, LLC DATE OF NAME CHANGE: 20170427 D 1 primary_doc.xml X0708 D LIVE 0001705194 CytoDel, INC. 423 WEST 127TH STREET NEW YORK NY NEW YORK 10027 646-820-0066 DELAWARE CytoDel, LLC Corporation true Philip A. Band c/o CytoDel, Inc. 423 W. 127th Street New York NY NEW YORK 10027 Executive Officer Director Andre Gudger c/o CytoDel, Inc. 423 W. 127th Street New York NY NEW YORK 10027 Director Charles Weiss c/o CytoDel, Inc. 423 W. 127th Street New York NY NEW YORK 10027 Director Margery Fischbein c/o CytoDel, Inc. 423 W. 127th Street New York NY NEW YORK 10027 Director Biotechnology Decline to Disclose 06b false 2018-01-05 false true false 50000 NONE None None None NONE NONE XX Unknown 99999 CA CALIFORNIA FL FLORIDA MI MICHIGAN NJ NEW JERSEY NY NEW YORK TX TEXAS false 6145000 3905000 2240000 As per the definitive offering documents, certain of the investors shall purchase, and the issuer shall sell, shares of preferred stock having a purchase price equal to the total remaining to be sold upon the satisfaction of certain milestones. false 11 0 0 0 false CytoDel, INC. /s/ Philip A. Band Philip A. Band Chief Executive Officer 2018-01-16